Skip to main content
Clinical Trials/NCT05571449
NCT05571449
Recruiting
N/A

Efficacy of the Use of 3D Printing Models in the Treatment of Tibial Plateau Fractures: a Prospective Randomized Clinical Trial

Pedro-José Torrijos-Garrido1 site in 1 country30 target enrollmentOctober 1, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Tibial Plateau Fracture
Sponsor
Pedro-José Torrijos-Garrido
Enrollment
30
Locations
1
Primary Endpoint
Fluoroscopy time.
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

TIBIA3D is a randomized, open and prospective clinical trail that evaluates the use of preoperative 3D printing in the surgical treatment of patients with tibial plateau fractures

Detailed Description

Randomized, open and prospective study. Once the surgical indication for osteosynthesis has been established after having suffered a tibial plateau fracture, the patients will be randomized in a 1:1 ratio to one of the tfollowing treatment groups: Control group: images obtained by plain radiography and computed tomography are used in the planning of osteosynthesis of the tibial plateau fracture. Experimental group: in the planning of tibial plateau fracture osteosynthesis, in addition to images obtained by plain radiography and computed tomography, a three-dimensional plastic model printed by processing the tomography images is used. Patients (or their legal representatives) must sign the consent before randomization. After surgery, a follow-up will be carried out at 3, 6 and 12 months, visits in which data will be collected regarding the physical examination, radiological examination, pain and questionnaires will be filled out regarding the functionality of the knee and perception of health status.

Registry
clinicaltrials.gov
Start Date
October 1, 2022
End Date
October 1, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Pedro-José Torrijos-Garrido
Responsible Party
Sponsor Investigator
Principal Investigator

Pedro-José Torrijos-Garrido

Principal Investigator

Puerta de Hierro University Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients with tibial plateau fracture requiring surgical treatment.
  • Age equal to or greater than 18 years.
  • Signature of informed consent in writing according to current legislation before collecting any information.

Exclusion Criteria

  • Pregnancy in progress.
  • Presence of serious systemic pathology or another situation that contraindicates treatment
  • Presence of other fractures in the ipsilateral femur or tibia that condition the surgical treatment of the tibial plateau fracture.
  • Findings in the physical examination, in the results of the tests or other medical, social or psychopathological factors that, in the opinion of the investigators, could negatively influence the study.
  • Inability to grant informed consent in the absence of a legal representative.
  • Inability to follow instructions or collaborate during the development of the study.

Outcomes

Primary Outcomes

Fluoroscopy time.

Time Frame: Week 1

Intraoperative fluoroscopy time will be counted after incision and before wound closure.

Surgical time

Time Frame: Week 1

Surgical time will include the time from skin incision to wound closure

Secondary Outcomes

  • Ease of surgical planning with 3d printing(Week 1)
  • Complications(Week 1 - 12 months)

Study Sites (1)

Loading locations...

Similar Trials